文献速递白血病MDS 与骨髓增殖性肿瘤造血干细胞移植与细胞治疗

家族性白血病中发现的RUNX1甲基化缺失使造血干细胞获得生存优势

Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.
PubMed 文献 · Blood · 2020-01-01

对3例急性髓系白血病(AML)家族行靶向深度测序发现新RUNX1突变R237K,该位点为蛋白质精氨酸甲基转移酶1甲基化位点。用RUNX1 R233K/R237K双突变小鼠证实,RUNX1甲基化缺失导致造血干细胞(HSC)静息丧失与扩增,并抑制内质网应激未折叠蛋白反应基因、辐射诱导的p53下游基因及后续凋亡,使HSC在应激下获得抗凋亡与生存优势。

要点

  • 家族性AML中鉴定出RUNX1 R237K突变,R237为蛋白质精氨酸甲基转移酶1甲基化位点。
  • RUNX1 R233K/R237K双突变小鼠中,RUNX1甲基化缺失致HSC静息丧失与扩增。
  • 甲基化缺失抑制Atf4、Ddit3、Gadd34及Bbc3、Pmaip1、Cdkn1a并减少HSC凋亡。

核心结论

  • HSC中RUNX1甲基化缺陷赋予应激条件下抗凋亡与生存优势,这是白血病前克隆的标志,可能使受累个体易患白血病。

研究设计与样本

  • 对1个发生3次AML的家族行靶向深度测序,鉴定出新的RUNX1突变R237K。
  • 使用RUNX1 R233K/R237K双突变小鼠,其中2个精氨酸至赖氨酸突变阻止RUNX1甲基化,以研究RUNX1甲基化的体内生物学意义。

主要发现

  • RUNX1甲基化缺失导致HSC静息丧失与扩增,并将表型HSC的基因组与表观基因组特征改变为预备的祖细胞状态。
  • RUNX1 R233/R237甲基化缺失抑制内质网应激诱导的未折叠蛋白反应基因Atf4、Ddit3和Gadd34,抑制辐射诱导的p53下游基因Bbc3、Pmaip1和Cdkn1a,并减少HSC后续凋亡。
  • 激活转录因子4被鉴定为RUNX1的直接转录靶标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RUNX1 is among the most frequently mutated genes in human leukemia, and the loss or dominant-negative suppression of RUNX1 function is found in myelodysplastic syndrome and acute myeloid leukemia (AML). How posttranslational modifications (PTMs) of RUNX1 affect its in vivo function, however, and whether PTM dysregulation of RUNX1 can cause leukemia are largely unknown. We performed targeted deep sequencing on a family with 3 occurrences of AML and identified a novel RUNX1 mutation, R237K. The mutated R237 residue is a methylation site by protein arginine methyltransferase 1, and loss of methylation reportedly impairs the transcriptional activity of RUNX1 in vitro. To explore the biologic significance of RUNX1 methylation in vivo, we used RUNX1 R233K/R237K double-mutant mice, in which 2 arginine-to-lysine mutations precluded RUNX1 methylation. Genetic ablation of RUNX1 methylation led to loss of quiescence and expansion of hematopoietic stem cells (HSCs), and it changed the genomic and epigenomic signatures of phenotypic HSCs to a poised progenitor state. Furthermore, loss of RUNX1 R233/R237 methylation suppressed endoplasmic reticulum stress-induced unfolded protein response genes, including Atf4, Ddit3, and Gadd34; the radiation-induced p53 downstream genes Bbc3, Pmaip1, and Cdkn1a; and subsequent apoptosis in HSCs. Mechanistically, activating transcription factor 4 was identified as a direct transcriptional target of RUNX1. Collectively, defects in RUNX1 methylation in HSCs confer resistance to apoptosis and survival advantage under stress conditions, a hallmark of a preleukemic clone that may predispose affected individuals to leukemia. Our study will lead to a better understanding of how dysregulation of PTMs can contribute to leukemogenesis.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Matsumura T, Nakamura-Ishizu A, Muddineni SSNA, et al. Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia. Blood. 2020. PMID: 32573733. doi:10.1182/blood.2019004292

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。